ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ELYM Eliem Therapeutics Inc

7.537
-0.123 (-1.61%)
Last Updated: 08:52:27
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,212
Bid Price 7.50
Ask Price 8.03
News -
Day High 7.78

Low
2.34

52 Week Range

High
11.55

Day Low 7.537
Share Name Share Symbol Market Stock Type
Eliem Therapeutics Inc ELYM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.123 -1.61% 7.537 08:52:27
Open Price Low Price High Price Close Price Previous Close
7.54 7.537 7.78 7.66
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
18 2,212 US$ 7.58 US$ 16,776 - 2.34 - 11.55
Last Trade Type Quantity Price Currency
08:52:27 239 US$ 7.537 USD

Eliem Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
207.9M 27.57M - 0 -35.12M -1.27 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Eliem Therapeutics News

Date Time Source News Article
6/14/202416:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
6/12/202415:42Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
6/12/202415:41Edgar (US Regulatory)Form 8-K - Current report
6/04/202407:05Edgar (US Regulatory)Form ARS - Annual Report to Security Holders
6/04/202407:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger..
5/17/202415:36Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to..
5/17/202415:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
5/15/202405:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/202417:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
4/11/202415:27PR Newswire (US)Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to..
4/11/202406:00GlobeNewswire Inc.Eliem Therapeutics Announces Agreement to Acquire Tenet..
3/04/202410:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ELYM Message Board. Create One! See More Posts on ELYM Message Board See More Message Board Posts

Historical ELYM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.629.257.518.4197,134-1.08-12.56%
1 Month8.099.587.0258.1592,327-0.553-6.84%
3 Months2.9011.552.525.23973,3364.64159.90%
6 Months2.7311.552.525.21455,5694.81176.08%
1 Year2.7811.552.345.09240,1564.76171.12%
3 Years16.2529.692.216.96132,243-8.71-53.62%
5 Years16.2529.692.216.96132,243-8.71-53.62%

Eliem Therapeutics Description

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Your Recent History

Delayed Upgrade Clock